You want your biopharmaceutical or device to go to market as fast as possible because you know it can improve lives. But, statistically speaking, low patient enrollment is going to stop your trial in its tracks. With every research delay, people are left suffering — waiting for the right treatment, diagnostic, or device. Time is running out!
Video